Business
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inflammatory diseases.
About this update from Dong-a St Co., Ltd.
[{"type":"text","content":"CAMBRIDGE, Mass., Aug. 20, 2025 /PRNewswire/ -- XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inflammatory diseases.","length":263,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/XtalPi Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/XtalPi Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":213,"url":"https://media.zenfs.com/en/prnewswire.com/096d1c8437cb84e2a88b2cfea6eea574"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kulhPIgmoSeVNZI4ag87kQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM3NTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/096d1c8437cb84e2a88b2cfea6eea574","width":400,"height":213}},"href":"https://mma.prnewswire.com/media/2374018/XtalPi_EN_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"This collaboration will be based on XtalPi's intelligent and automated drug discovery platform, which integrates artificial intelligence (AI), quantum physics, and large-scale automated robotic experiments. The two companies plan to co-identify targets and discover first-in-class or best-in-class drug candidates using XtalPi's proprietary AI-driven drug discovery platform. The XtalPi platform combines the speed and generative power of AI with the accuracy of its robotic lab-in-the-loop to accelerate drug discovery and vastly expand the explorable chemical space. This integrated workflow spans deep-learning-based molecule design, quantum physics and molecular dynamics simulations for predicting drug-target interactions, automated chemical synthesis, and experimental validation of candidate compounds' key pharmaceutical properties.","length":853,"tagName":"p"},{"type":"text","content":"Leveraging its expertise in immunology and inflammation as well as its experience in small molecule drug development, Dong-A ST will actively participate throughout the entire R&D process—including candidate validation, efficacy and safety testing, and the formulation of preclinical and clinical development strategies. The company also plans to explore strategies for pipeline expansion and assess commercialization potential.","length":432,"tagName":"p"},{"type":"text","content":"Through this partnership, ...